Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Entera Bio Ltd. (ENTX) had Pre-Tax Income of $-7.31M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-7.31M |
|
-- |
|
-- |
|
$4.56M |
|
$-4.56M |
|
$-2.75M |
|
|
Pre-Tax Income |
$-7.31M |
$-7.31M |
|
$-7.31M |
|
$-7.31M |
|
$-7.31M |
|
$-7.31M |
|
$-4.56M |
|
$-4.55M |
|
50.45M |
|
50.45M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$18.90M |
|
$0.12M |
|
$0.58M |
|
$19.48M |
|
$2.10M |
|
-- |
|
$10.11M |
|
$12.21M |
|
$7.27M |
|
$7.27M |
|
$7.27M |
|
49.29M |
|
| Cash Flow Statement Financials | |
$-6.55M |
|
$-0.00M |
|
$10.09M |
|
$14.97M |
|
$18.53M |
|
$3.55M |
|
$1.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-100.63% |
|
-100.63% |
|
-37.54% |
|
-100.63% |
|
$0.15 |
|
$-0.13 |
|
$-0.13 |
|